Adagio Medical SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KNov. 5, 2026, 8 a.m. ETView on SEC.gov Our explainer
Amendments to articles or bylaws; fiscal year change · Financial statements and exhibits
AI summary, unreviewedAdagio Medical Holdings announces 1-for-30 reverse stock split effective November 6, 2026, with trading split-adjusted from November 9
8-KOct. 26, 2026, 8 a.m. ETView on SEC.gov
Submission of matters to a vote of security holders
AI summary, unreviewedAdagio Medical Holdings Approves Reverse Stock Split Authority at 1-for-10 to 1-for-500 Ratio
4Oct. 13, 2026, 6:19 a.m. ETView on SEC.gov
8-KOct. 1, 2026, 5:08 p.m. ETView on SEC.gov
Unregistered sales of equity securities
8-KSept. 23, 2026, 8:01 a.m. ETView on SEC.gov
Costs of exit or disposal activities · Other events · Financial statements and exhibits
SCHEDULE 13G/AAug. 14, 2026, 5:04 p.m. ETView on SEC.gov
8-KAug. 14, 2026, 4:31 p.m. ETView on SEC.gov
Delisting notice / failure to meet listing standard
8-KAug. 13, 2026, 4:37 p.m. ETView on SEC.gov
Regulation FD disclosure · Financial statements and exhibits
4Aug. 12, 2026, 1:58 p.m. ETView on SEC.gov
4Aug. 12, 2026, 1:36 p.m. ETView on SEC.gov
4Aug. 12, 2026, 2:37 p.m. ETView on SEC.gov
4Aug. 12, 2026, 1:30 p.m. ETView on SEC.gov
4Aug. 12, 2026, 1:47 p.m. ETView on SEC.gov
4Aug. 12, 2026, 1:40 p.m. ETView on SEC.gov
8-KAug. 11, 2026, 8:30 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
10-QAug. 11, 2026, 8:30 a.m. ETView on SEC.gov
SCHEDULE 13G/AJuly 28, 2026, 4:49 p.m. ETView on SEC.gov